Compound Evidence File
#EC-2026-0071
CJC-1295 w/o DAC 10mg + IPA 10mg Blend
Filed under Peptides. The bureau holds 175 laboratory returns for this compound from 74 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
74 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 7 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 10.0 | 9.9 | 10.0 | 2 Mar 2026 | 14 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 10.0 | 10.0 | 10.0 | 6 Apr 2026 | 21 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 9.9 | 10.0 | 26 Feb 2026 | 24 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 10.0 | 10.0 | 10.0 | 26 Mar 2026 | 26 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 10.0 | 10.0 | 10.0 | 4 Apr 2026 | 22 Jun 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 4 | 10.0 | 9.9 | 10.0 | 17 Apr 2026 | 2 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 10.0 | 9.9 | 10.0 | 23 Jan 2026 | 15 Aug 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 10.0 | 10.0 | 10.0 | 5 Feb 2026 | 6 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 9.9 | 10.0 | 2 Jan 2026 | 5 Jul 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 10.0 | 10.0 | 10.0 | 16 May 2026 | 10 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 10.0 | 10.0 | 10.0 | 25 Apr 2026 | 6 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 10.0 | 10.0 | 10.0 | 20 Dec 2025 | 18 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 10.0 | 10.0 | 10.0 | 7 Jan 2026 | 16 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 10.0 | 10.0 | 10.0 | 23 Feb 2026 | 19 Mar 2026 |
| LipeptidesCASE #VI-2026-0863 | X | 1 | 10.0 | 10.0 | 10.0 | 24 Apr 2025 | 24 Apr 2025 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 9.9 | 9.9 | 10.0 | 11 Apr 2026 | 21 Jun 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 9.9 | 9.9 | 10.0 | 20 Jul 2026 | 27 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 9.9 | 9.9 | 10.0 | 1 May 2026 | 1 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 9.9 | 9.9 | 10.0 | 1 Apr 2026 | 28 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 9.9 | 9.9 | 10.0 | 13 Apr 2026 | 14 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 10.0 | 25 Feb 2026 | 7 May 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 10.0 | 1 Apr 2026 | 13 Apr 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 2 | 9.5 | 9.0 | 10.0 | 24 May 2026 | 24 May 2026 |
| Xingtai Pukelai Technology CoCASE #VI-2026-0850 | X | 1 | 9.5 | 9.5 | 9.5 | 8 Jul 2025 | 8 Jul 2025 |
| AKS ChemCASE #VI-2026-0313 | X | 1 | 8.8 | 8.8 | 8.8 | 2 Jul 2025 | 2 Jul 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 7 | 8.7 | 7.8 | 9.8 | 23 May 2026 | 23 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 6 | 8.7 | 7.3 | 9.5 | 25 May 2026 | 25 May 2026 |
| Huaian Hanyou PeptideCASE #VI-2026-0297 | X | 1 | 8.7 | 8.7 | 8.7 | 7 May 2025 | 7 May 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 4 | 8.6 | 7.7 | 9.3 | 24 May 2026 | 24 May 2026 |
| Hunan GoodPeptides Biotech CoCASE #VI-2026-0370 | X | 1 | 8.6 | 8.6 | 8.6 | 17 Dec 2024 | 17 Dec 2024 |
| NextechLabsCASE #VI-2026-0285 | X | 3 | 8.5 | 7.3 | 9.9 | 27 Feb 2025 | 24 May 2026 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 8.4 | 8.4 | 8.4 | 17 Dec 2024 | 17 Dec 2024 |
| Risynth BioCASE #VI-2026-0672 | X | 1 | 8.4 | 8.4 | 8.4 | 2 Jul 2025 | 2 Jul 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 6 | 8.3 | 7.6 | 9.3 | 24 May 2026 | 24 May 2026 |
| Peptide CraftersCASE #VI-2026-0994 | X | 1 | 8.3 | 8.3 | 8.3 | 2 Jul 2025 | 2 Jul 2025 |
| Paradigm PeptideCASE #VI-2026-0759 | X | 1 | 8.2 | 8.2 | 8.2 | 2 Jul 2025 | 2 Jul 2025 |
| Planet PeptideCASE #VI-2026-0092 | X | 3 | 8.1 | 6.1 | 10.0 | 2 Apr 2025 | 26 Jan 2026 |
| Amino LairCASE #VI-2026-0413 | X | 1 | 7.8 | 7.8 | 7.8 | 20 Jun 2025 | 20 Jun 2025 |
| YimeiCASE #VI-2026-0081 | X | 5 | 7.6 | 6.5 | 10.0 | 14 Jan 2025 | 19 Jan 2026 |
| Top PeptideCASE #VI-2026-0721 | X | 1 | 7.6 | 7.6 | 7.6 | 13 Feb 2025 | 13 Feb 2025 |
| Welon Peptide SolutionsCASE #VI-2026-0478 | X | 1 | 7.5 | 7.5 | 7.5 | 3 Jul 2025 | 3 Jul 2025 |
| Verified PeptidesCASE #VI-2026-0407 | X | 3 | 7.4 | 6.7 | 8.2 | 2 Jul 2025 | 26 Jan 2026 |
| Skye PeptidesCASE #VI-2026-0451 | X | 6 | 7.2 | 4.9 | 8.1 | 16 Mar 2025 | 26 Jan 2026 |
| Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634 | X | 2 | 7.2 | 5.7 | 8.6 | 9 Jun 2025 | 19 Jan 2026 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 7.2 | 7.2 | 7.2 | 2 Apr 2025 | 2 Apr 2025 |
| LN PeptidesCASE #VI-2026-0781 | X | 1 | 7.1 | 7.1 | 7.1 | 21 May 2025 | 21 May 2025 |
| BeiBangAnCASE #VI-2026-0899 | X | 1 | 7.0 | 7.0 | 7.0 | 24 Apr 2025 | 24 Apr 2025 |
| Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 | X | 1 | 7.0 | 7.0 | 7.0 | 21 May 2025 | 21 May 2025 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | X | 2 | 6.9 | 6.7 | 7.1 | 3 Jun 2025 | 21 May 2026 |
| OmegAminoCASE #VI-2026-0014 | X | 1 | 6.9 | 6.9 | 6.9 | 11 Jun 2025 | 11 Jun 2025 |
| Simple PeptideCASE #VI-2026-0782 | X | 2 | 6.8 | 5.5 | 8.2 | 24 Apr 2025 | 25 May 2026 |
| Zhang TYCASE #VI-2026-0070 | X | 1 | 6.7 | 6.7 | 6.7 | 13 Feb 2025 | 13 Feb 2025 |
| Paramount PeptidesCASE #VI-2026-0550 | X | 2 | 6.5 | 6.2 | 6.7 | 3 Jun 2025 | 24 May 2026 |
| HK PeptidesCASE #VI-2026-0140 | X | 9 | 6.3 | 3.6 | 8.0 | 14 Jan 2025 | 21 May 2026 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | X | 1 | 6.2 | 6.2 | 6.2 | 2 Apr 2025 | 2 Apr 2025 |
| Pure Tested PeptidesCASE #VI-2026-0225 | X | 1 | 6.1 | 6.1 | 6.1 | 8 Jul 2025 | 8 Jul 2025 |
| Platinum CryoCASE #VI-2026-0406 | X | 2 | 5.3 | 4.6 | 6.0 | 20 Jun 2025 | 20 May 2026 |
| SRY LabsCASE #VI-2026-0657 | X | 2 | 5.3 | 4.8 | 5.9 | 28 Mar 2025 | 19 Jan 2026 |
| ScienceCASE #VI-2026-0636 | X | 1 | 5.3 | 5.3 | 5.3 | 2 Jul 2025 | 2 Jul 2025 |
| Hangzhou Youngpeptide Biotechnology HYBCASE #VI-2026-0347 | X | 1 | 5.1 | 5.1 | 5.1 | 13 Jun 2025 | 13 Jun 2025 |
| Shandong Aishi BiotechnologyCASE #VI-2026-0308 | X | 1 | 5.0 | 5.0 | 5.0 | 2 Jul 2025 | 2 Jul 2025 |
| HybiopeptidesCASE #VI-2026-0305 | X | 1 | 4.0 | 4.0 | 4.0 | 20 Jun 2025 | 20 Jun 2025 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 4.0 | 4.0 | 4.0 | 7 May 2025 | 7 May 2025 |
| Peptides 4 ResearchCASE #VI-2026-0511 | X | 1 | 3.8 | 3.8 | 3.8 | 13 Jun 2025 | 13 Jun 2025 |
| Richards Biotech Simply RichardsCASE #VI-2026-0307 | X | 1 | 2.7 | 2.7 | 2.7 | 11 Jun 2025 | 11 Jun 2025 |
| Alimo PeptideCASE #VI-2026-0524 | X | 1 | 1.8 | 1.8 | 1.8 | 3 Jun 2025 | 3 Jun 2025 |
| PeptiLab ResearchCASE #VI-2026-0267 | X | 1 | 1.3 | 1.3 | 1.3 | 16 Mar 2025 | 16 Mar 2025 |
| PepKitsCASE #VI-2026-0320 | X | 1 | 0.6 | 0.6 | 0.6 | 17 Dec 2024 | 17 Dec 2024 |
| Weifang Xingbei International TradeCASE #VI-2026-0766 | X | 1 | 0.4 | 0.4 | 0.4 | 6 May 2025 | 6 May 2025 |
| Guangzhou Yuao TradingCASE #VI-2026-0787 | X | 1 | 0.1 | 0.1 | 0.1 | 24 Apr 2025 | 24 Apr 2025 |
| Lejian Biotech PeptideCASE #VI-2026-0746 | X | 1 | 0.0 | 0.0 | 0.0 | 24 Apr 2025 | 24 Apr 2025 |
| Marvel PeptideCASE #VI-2026-0507 | X | 1 | 0.0 | 0.0 | 0.0 | 28 Mar 2025 | 28 Mar 2025 |
Open any subject to view the batch-level evidence for CJC-1295 w/o DAC 10mg + IPA 10mg Blend alone.